|
|
|
Insider
Information: |
Murphy Andrew J |
Relationship: |
EVP Research |
City: |
Tarrytown |
State: |
NY |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
48,306 |
|
Indirect Shares
|
4,310 |
|
|
Direct
Value |
$47,564,020 |
|
|
Indirect Value
|
$4,243,798 |
|
|
Total
Shares |
52,616 |
|
|
Total
Value |
$51,807,818 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Regeneron Pharmaceuticals Inc |
REGN |
EVP Research |
2024-03-14 |
48,306 |
2024-03-14 |
4,310 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
52 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
REGN |
Regeneron Pharmaceuticals... |
EVP ResearchOfficer |
|
2019-12-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
45,326 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP ResearchOfficer |
|
2019-12-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,212 |
|
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2019-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
12,625 |
57,951 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2020-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
10,214 |
57,350 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2021-08-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,645 |
55,705 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2021-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,462 |
59,167 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2022-11-14 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,360 |
57,110 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2022-12-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,129 |
60,747 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2023-05-09 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,326 |
59,421 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2023-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,199 |
61,737 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2020-10-22 |
4 |
OE |
$30.63 |
$199,926 |
D/D |
5,185 |
47,136 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2022-12-09 |
4 |
D |
$753.28 |
$370,614 |
D/D |
(492) |
56,618 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2020-07-13 |
4 |
OE |
$30.63 |
$398,190 |
D/D |
13,000 |
54,951 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2020-11-16 |
4 |
OE |
$30.63 |
$420,734 |
D/D |
13,736 |
60,872 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2021-12-11 |
4 |
D |
$664.34 |
$463,045 |
D/D |
(697) |
58,470 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2023-12-08 |
4 |
D |
$843.79 |
$745,067 |
D/D |
(883) |
58,538 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2021-12-09 |
4 |
OE |
$52.03 |
$858,495 |
D/D |
16,500 |
75,667 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2021-11-15 |
4 |
OE |
$52.03 |
$862,605 |
D/D |
16,579 |
72,284 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2020-07-14 |
4 |
AS |
$630.77 |
$1,507,677 |
D/D |
(2,380) |
41,951 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2022-02-14 |
4 |
OE |
$179.13 |
$1,791,300 |
D/D |
10,000 |
68,470 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2022-05-16 |
4 |
OE |
$179.13 |
$1,791,300 |
D/D |
10,000 |
68,470 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2022-08-15 |
4 |
OE |
$179.13 |
$1,791,300 |
D/D |
10,000 |
68,470 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2022-11-14 |
4 |
OE |
$179.13 |
$1,791,300 |
D/D |
10,000 |
67,110 |
0 |
- |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2022-02-15 |
4 |
AS |
$622.09 |
$2,227,851 |
D/D |
(3,540) |
58,470 |
0 |
% |
|
REGN |
Regeneron Pharmaceuticals... |
EVP Research |
|
2022-08-16 |
4 |
AS |
$639.85 |
$2,267,600 |
D/D |
(3,513) |
58,470 |
0 |
% |
|
52 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|